ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$32,587 | -$36,355 | -$30,021 | -$36,307 |
| Dep. & Amort. | $288 | $310 | $302 | $304 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,631 | $6,574 | $0 | $0 |
| Change in WC | $2,143 | -$780 | -$8,486 | $4,380 |
| Other Non-Cash | -$587 | -$591 | $5,430 | $3,569 |
| Operating Cash Flow | -$25,112 | -$30,842 | -$32,775 | -$28,054 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$35 | -$63 | -$387 | -$219 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$165,500 | -$124,367 | -$64,663 | -$34,626 |
| Inv. Sales/Matur. | $55,000 | $47,500 | $87,500 | $77,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$110,535 | -$76,930 | $22,450 | $42,655 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $110,444 | $133,925 | $253 | $575 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$993 | $377 | $0 | $0 |
| Financing Cash Flow | $109,451 | $134,302 | $253 | $575 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$26,196 | $26,530 | -$10,072 | $15,176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,355 | $49,825 | $59,406 | $44,230 |
| End Cash | $50,159 | $76,355 | $49,334 | $59,406 |
| Free Cash Flow | -$25,147 | -$30,905 | -$33,162 | -$28,273 |